ArticleExperimental and therapeutic medicine2014

BIIB021, an Hsp90 inhibitor, effectively kills a myelodysplastic syndrome cell line via the activation of caspases and inhibition of PI3K/Akt and NF-κB pathway proteins.

Shengyun Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.